泛素连接酶和缀合酶在靶向癌症治疗中的作用。
Role of Ubiquitin Ligases and Conjugases in Targeted Cancer Therapy.
作者信息
Vriend Jerry
机构信息
Department of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
出版信息
Cancers (Basel). 2023 Jul 1;15(13):3460. doi: 10.3390/cancers15133460.
Abstract
The ubiquitin proteasome system regulates the activity of many short-lived proteins in cells [...].
摘要
泛素蛋白酶体系统调节细胞中许多短命蛋白质的活性[...]。
相似文献
1
Role of Ubiquitin Ligases and Conjugases in Targeted Cancer Therapy.
Cancers (Basel). 2023 Jul 1;15(13):3460. doi: 10.3390/cancers15133460.
2
Ubiquitin Proteasome Gene Signatures in Ependymoma Molecular Subtypes.
Int J Mol Sci. 2022 Oct 15;23(20):12330. doi: 10.3390/ijms232012330.
3
The pineal gland: A model for adrenergic modulation of ubiquitin ligases.
PLoS One. 2017 Feb 17;12(2):e0172441. doi: 10.1371/journal.pone.0172441. eCollection 2017.
4
Ubiquitin Proteasome Pathway Transcriptome in Epithelial Ovarian Cancer.
Cancers (Basel). 2021 May 28;13(11):2659. doi: 10.3390/cancers13112659.
5
Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin.
Cell Mol Neurobiol. 2023 May;43(4):1425-1452. doi: 10.1007/s10571-022-01261-0. Epub 2022 Jul 27.
6
Role of E3 ubiquitin ligases in lung cancer.
World J Clin Oncol. 2013 Aug 10;4(3):58-69. doi: 10.5306/wjco.v4.i3.58.
7
Seek and destroy: the ubiquitin----proteasome system in cardiac disease.
Curr Hypertens Rep. 2009 Dec;11(6):396-405. doi: 10.1007/s11906-009-0069-7.
8
Ubiquitin proteasome system in immune regulation and therapeutics.
Curr Opin Pharmacol. 2022 Dec;67:102310. doi: 10.1016/j.coph.2022.102310. Epub 2022 Oct 23.
9
Targeting E3 ubiquitin ligases for cancer therapy.
Cancer Biol Ther. 2003 Nov-Dec;2(6):623-9.
10
Analysis of Proteasome-Associated Ubiquitin Ligase Activity.
Methods Mol Biol. 2023;2581:57-67. doi: 10.1007/978-1-0716-2784-6_5.
本文引用的文献
1
AtomNet-Aided OTUD7B Inhibitor Discovery and Validation.
Cancers (Basel). 2023 Jan 14;15(2):517. doi: 10.3390/cancers15020517.
2
PROTAC therapy as a new targeted therapy for lung cancer.
Mol Ther. 2023 Mar 1;31(3):647-656. doi: 10.1016/j.ymthe.2022.11.011. Epub 2022 Nov 22.
3
The E3 Ligases in Cervical Cancer and Endometrial Cancer.
Cancers (Basel). 2022 Oct 30;14(21):5354. doi: 10.3390/cancers14215354.
4
Pan-Cancer Bioinformatics Analysis of Gene UBE2C.
Front Genet. 2022 Apr 27;13:893358. doi: 10.3389/fgene.2022.893358. eCollection 2022.
5
The Emerging Role of E3 Ubiquitin Ligase SMURF2 in the Regulation of Transcriptional Co-Repressor KAP1 in Untransformed and Cancer Cells and Tissues.
Cancers (Basel). 2022 Mar 22;14(7):1607. doi: 10.3390/cancers14071607.
6
Ubiquitin conjugating enzyme E2 C (UBE2C) may play a dual role involved in the progression of thyroid carcinoma.
Cell Death Discov. 2022 Mar 24;8(1):130. doi: 10.1038/s41420-022-00935-4.
7
Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors.
Sci Rep. 2022 Mar 18;12(1):4696. doi: 10.1038/s41598-022-08210-3.
8
Clinical considerations for the design of PROTACs in cancer.
Mol Cancer. 2022 Mar 7;21(1):67. doi: 10.1186/s12943-022-01535-7.
9
Characterization of the pVHL Interactome in Human Testis Using High-Throughput Library Screening.
Cancers (Basel). 2022 Feb 17;14(4):1009. doi: 10.3390/cancers14041009.
10
E3 ligase RNF167 and deubiquitinase STAMBPL1 modulate mTOR and cancer progression.
Mol Cell. 2022 Feb 17;82(4):770-784.e9. doi: 10.1016/j.molcel.2022.01.002. Epub 2022 Feb 2.
Zotero 插件